Intestinal permeability and contractility in murine colitis

Mediators of Inflammation

Volumn 7, Issue 3, 1998, Pages 163-168

  Van Meeteren, M E ^a   Van Bergeijk, J D ^b   Van Dijk, A P M ^a   Tak, C J A M ^a   Meijssen, M A C ^b   Zijlstra, F J ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Contractile activity; Dextran induced colitis; Mannitol; Mice; Permeability; Polyethylene glycol 400

Indexed keywords

DEXTRAN; MACROGOL 400; MANNITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; COLITIS; CONFERENCE PAPER; CONTROLLED STUDY; HISTOLOGY; INTESTINE CONTRACTION; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; INTESTINE PRESSURE; MEDIATOR RELEASE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION;

ANIMALS; COLITIS; FEMALE; GASTROINTESTINAL MOTILITY; INTERFERON TYPE II; INTESTINES; MICE; MICE, INBRED BALB C; MUSCLE CONTRACTION; PERMEABILITY;

ANIMALIA; MURINAE;

EID: 0031821614     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629359891090     Document Type: Conference Paper

References (15)

1. Travis S, Mcnzies I. Intestinal permeability: functional assessment and significance Clin Sci 1992; 82: 471-488.
2. Collins SM. The immunomodulalion of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 1996; 111: 1683-1699.
3. 51Cr-EDTA in patients with active inflammatory bowel disease. Clin Invest Med 1988; 11: 151-155.
4. Reddy SN, Bazzocchi G, Chan S, Akashi K, Villanueva-Meye J, Yanni G, Mena I, Snape WJ. Colonic motility and transit in health and ulcerative colitis. Gastroenterology 1991; 101: 1289-1297.
5. Pecters M, Hiele M, Ghoos Y, Huysmans V, Geboes K, Vantrappen G, Rutgccrts P. Test conditions greatly influence permcation of water soluble molecules through the intestinal mucosa: need for standardisation. Gut 1994; 35: 1404-1408.
6. 13C-mannitol methods for intestinal permeability. Scand J Gastroenterol 1993; 28: 274-280.
7. 51Chromiumlabeled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology 1983; 85: 318-322.
8. Hollander D. The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease. Scand J Gastroenterol 1992; 27: 721-726.
9. Bjarnason I, Macpherson A, Hollander D. Intestinal permeability: an overview Gastroenterology 1995; 108: 1566-1581.
10. Bijlsma PB, Peeters RA, Groot JA, Dekker PR, Taminiau JAJM, van der Meer R. Differential in vivo and in vitro intestinal permeability to lactulose and mannitol in animals and humans: a hypothesis. Gastroenterology 1995; 108: 687-696.
11. Meyers BS, Dempsey DT, Yasar S, Martin JS, Parkman HP, Ryan JP. Acute experimental distal colitis alters colonic transit in rats. J Surg Res 1997; 69: 107-112.
12. Krugliak P. Hollander D, Schlaepfer CC, Nguyen H, Ma TY. Mechanisms and sites of mannitol permeability of small and large intestine in the rat. Dig Dis Sci 1994; 39: 796-801.
13. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP. Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1991; 107: 1643-1652.
14. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694-702.
15. van Dijk APM, Keuskamp ZJ, Wilson JMP, Zijlstra FJ. Sequential release of cytokines, lipid mediators and nitric oxide in experimental colitis. Mediators Inflamm 1995; 4: 180-190.